Business Description
Relief Therapeutics Holding SA
ISIN : CH1251125998
Compare
Compare
Traded in other countries / regions
RLF.SwitzerlandRLFTF.USARLFz.UKV6M.Germany IPO Date
2013-05-17Description
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development such as RLF-TD011, and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast among others. Geographically the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.92 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -8.15 | |||||
| Beneish M-Score | -1.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -108 | |||||
| 3-Year EPS without NRI Growth Rate | 22.1 | |||||
| 3-Year FCF Growth Rate | 20.2 | |||||
| 3-Year Book Growth Rate | -20.4 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.4 | |||||
| 9-Day RSI | 49.75 | |||||
| 14-Day RSI | 46.27 | |||||
| 6-1 Month Momentum % | -37.63 | |||||
| 12-1 Month Momentum % | 21507.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.65 | |||||
| Quick Ratio | 2.57 | |||||
| Cash Ratio | 2.11 | |||||
| Days Inventory | 86.48 | |||||
| Days Sales Outstanding | 70.66 | |||||
| Days Payable | 338.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.6 | |||||
| Shareholder Yield % | -32.69 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.23 | |||||
| Operating Margin % | -327.83 | |||||
| Net Margin % | -1627.4 | |||||
| FCF Margin % | -299.32 | |||||
| ROE % | -100.87 | |||||
| ROA % | -75.34 | |||||
| ROIC % | -15.27 | |||||
| ROC (Joel Greenblatt) % | -3763.23 | |||||
| ROCE % | -91.22 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.49 | |||||
| PB Ratio | 0.31 | |||||
| EV-to-EBIT | -0.04 | |||||
| EV-to-EBITDA | -0.04 | |||||
| EV-to-Forward-EBITDA | -1.09 | |||||
| EV-to-Revenue | 0.74 | |||||
| EV-to-Forward-Revenue | 0.43 | |||||
| EV-to-FCF | -0.25 | |||||
| Earnings Yield (Greenblatt) % | -2500 | |||||
| FCF Yield % | -112.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Relief Therapeutics Holding SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 6.033 | ||
| EPS (TTM) (CHF) | 0 | ||
| Beta | 95.28 | ||
| Volatility % | 49638.97 | ||
| 14-Day RSI | 46.27 | ||
| 14-Day ATR (CHF) | 0.02781 | ||
| 20-Day SMA (CHF) | 1.25125 | ||
| 12-1 Month Momentum % | 21507.14 | ||
| 52-Week Range (CHF) | 0.0056 - 4.5 | ||
| Shares Outstanding (Mil) | 12.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Relief Therapeutics Holding SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Relief Therapeutics Holding SA Stock Events
| Event | Date | Price(CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Relief Therapeutics Holding SA Frequently Asked Questions
What is Relief Therapeutics Holding SA(CHIX:RLFz)'s stock price today?
The current price of CHIX:RLFz is CHF1.25. The 52 week high of CHIX:RLFz is CHF4.50 and 52 week low is CHF0.01.
When is next earnings date of Relief Therapeutics Holding SA(CHIX:RLFz)?
The next earnings date of Relief Therapeutics Holding SA(CHIX:RLFz) is 2024-09-13 Est..
Does Relief Therapeutics Holding SA(CHIX:RLFz) pay dividends? If so, how much?
Relief Therapeutics Holding SA(CHIX:RLFz) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers